Medifast (MED) Competitors $18.18 +0.86 (+4.97%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends MED vs. USNA, NUS, NATR, VERU, EL, PBH, IPAR, HLF, FARM, and JVAShould you be buying Medifast stock or one of its competitors? The main competitors of Medifast include USANA Health Sciences (USNA), Nu Skin Enterprises (NUS), Nature's Sunshine Products (NATR), Veru (VERU), Estée Lauder Companies (EL), Prestige Consumer Healthcare (PBH), Inter Parfums (IPAR), Herbalife (HLF), Farmer Bros. (FARM), and Coffee (JVA). Medifast vs. USANA Health Sciences Nu Skin Enterprises Nature's Sunshine Products Veru Estée Lauder Companies Prestige Consumer Healthcare Inter Parfums Herbalife Farmer Bros. Coffee Medifast (NYSE:MED) and USANA Health Sciences (NYSE:USNA) are both small-cap consumer staples companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, community ranking, analyst recommendations, valuation, profitability, earnings, dividends and risk. Is MED or USNA more profitable? USANA Health Sciences has a net margin of 6.30% compared to Medifast's net margin of 1.09%. Medifast's return on equity of 15.98% beat USANA Health Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Medifast1.09% 15.98% 11.01% USANA Health Sciences 6.30%10.64%8.48% Does the MarketBeat Community prefer MED or USNA? USANA Health Sciences received 13 more outperform votes than Medifast when rated by MarketBeat users. However, 63.62% of users gave Medifast an outperform vote while only 60.55% of users gave USANA Health Sciences an outperform vote. CompanyUnderperformOutperformMedifastOutperform Votes38363.62% Underperform Votes21936.38% USANA Health SciencesOutperform Votes39660.55% Underperform Votes25839.45% Which has more risk & volatility, MED or USNA? Medifast has a beta of 1.13, indicating that its share price is 13% more volatile than the S&P 500. Comparatively, USANA Health Sciences has a beta of 0.89, indicating that its share price is 11% less volatile than the S&P 500. Do institutionals & insiders hold more shares of MED or USNA? 95.5% of Medifast shares are owned by institutional investors. Comparatively, 54.3% of USANA Health Sciences shares are owned by institutional investors. 2.5% of Medifast shares are owned by company insiders. Comparatively, 0.3% of USANA Health Sciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Do analysts rate MED or USNA? Medifast currently has a consensus price target of $17.00, suggesting a potential downside of 6.49%. USANA Health Sciences has a consensus price target of $35.00, suggesting a potential downside of 11.44%. Given Medifast's higher possible upside, equities research analysts clearly believe Medifast is more favorable than USANA Health Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Medifast 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00USANA Health Sciences 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has better valuation & earnings, MED or USNA? Medifast has higher revenue and earnings than USANA Health Sciences. USANA Health Sciences is trading at a lower price-to-earnings ratio than Medifast, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMedifast$1.07B0.19$99.42M$0.6627.55USANA Health Sciences$861.97M0.87$63.79M$2.8313.96 Does the media refer more to MED or USNA? In the previous week, Medifast's average media sentiment score of 1.00 beat USANA Health Sciences' score of 0.00 indicating that Medifast is being referred to more favorably in the media. Company Overall Sentiment Medifast Positive USANA Health Sciences Neutral SummaryMedifast beats USANA Health Sciences on 11 of the 15 factors compared between the two stocks. Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…Get Your Free Gold Guide Get Medifast News Delivered to You Automatically Sign up to receive the latest news and ratings for MED and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MED vs. The Competition Export to ExcelMetricMedifastfood preparations & kindred products IndustryStaples SectorNYSE ExchangeMarket Cap$198.89M$4.57B$14.53B$19.87BDividend YieldN/A2.91%2.68%3.53%P/E Ratio27.5511.5723.9742.89Price / Sales0.191.313.6918.10Price / Cash1.6711.8819.1417.86Price / Book0.982.245.895.52Net Income$99.42M$193.18M$581.83M$986.45M7 Day Performance-7.10%1.00%-0.53%-0.22%1 Month Performance0.39%-0.99%-3.91%0.12%1 Year Performance-73.07%55.45%9.45%23.71% Medifast Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MEDMedifast2.513 of 5 stars$18.18+5.0%$17.00-6.5%-73.1%$189.44M$1.07B27.55870Positive NewsUSNAUSANA Health Sciences2.8323 of 5 stars$39.52+1.2%$35.00-11.4%-14.5%$744.09M$921.01M13.961,800NUSNu Skin Enterprises3.6991 of 5 stars$7.49-1.3%$8.88+18.5%-57.3%$377.31M$1.97B0.003,700NATRNature's Sunshine Products2.7901 of 5 stars$16.00+0.2%$19.00+18.8%-7.5%$295.68M$445.32M18.18814Positive NewsVERUVeru2.3517 of 5 stars$0.63flat$4.00+539.7%-36.6%$91.81M$16.30M0.00189Gap UpELEstée Lauder Companies4.9221 of 5 stars$65.34+0.8%$98.57+50.9%-46.6%$23.26B$15.61B116.6862,000Analyst ForecastInsider TradePBHPrestige Consumer Healthcare3.3849 of 5 stars$82.67+0.3%$83.67+1.2%+40.5%$4.07B$1.13B20.11540IPARInter Parfums3.8214 of 5 stars$127.12+1.6%$157.50+23.9%+1.8%$4.01B$1.32B27.28530HLFHerbalife4.1247 of 5 stars$8.42+8.9%$9.90+17.6%-33.5%$778.11M$5.06B9.909,200FARMFarmer Bros.4.0749 of 5 stars$2.00+2.6%$5.25+162.5%-20.0%$41.47M$341.09M0.001,003Analyst RevisionJVACoffee1.5522 of 5 stars$3.39+4.0%N/A+308.7%$0.00$68.17M16.9580Analyst Forecast Related Companies and Tools Related Companies USNA Competitors NUS Competitors NATR Competitors VERU Competitors EL Competitors PBH Competitors IPAR Competitors HLF Competitors FARM Competitors JVA Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:MED) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medifast, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medifast With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MED Stock Alerts